SCHEMBL17799694

SCHEMBL17799694

Cc1ncccc1C(=O)N[C@H]1CC[C@H]1c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 1/20 0.47
▸ TAS1R3 Q7RTX0 2/20 0.41
▸ TAS1R1 Q7RTX1 2/20 0.41
▸ TAS1R2 Q8TE23 2/20 0.41
▸ SSTR4 P31391 2/20 0.41
▸ GRIA4 P48058 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ AKT1 P31749 4/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CNR2 P34972 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CRHR1 P34998 1/20 0.38
▸ FPR1 P21462 2/20 0.38
▸ FPR2 P25090 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16371875 1.00 P2RX7 (0.47) P2RX7TAS1R3TAS1R1TAS1R2SSTR4
SCHEMBL16372250 0.84 P2RX7 (0.43) P2RX7TAS1R3TAS1R1TAS1R2CRHR1
SCHEMBL17799715 0.84 P2RX7 (0.43) P2RX7TAS1R3TAS1R1TAS1R2CRHR1
SCHEMBL17799641 0.83 GRM5 (0.51) TAS1R3TAS1R1TAS1R2SSTR4AKT1
SCHEMBL16372224 0.83 GRM5 (0.51) TAS1R3TAS1R1TAS1R2SSTR4AKT1
SCHEMBL17799665 0.83 AKT1 (0.40) GRIA4AKT1FPR1FPR2
SCHEMBL16371914 0.83 AKT1 (0.40) GRIA4AKT1FPR1FPR2
SCHEMBL16371986 0.83 NPC1 (0.51) TAS1R3TAS1R1TAS1R2RAB9ANPC1
SCHEMBL17799699 0.83 NPC1 (0.51) TAS1R3TAS1R1TAS1R2RAB9ANPC1
SCHEMBL17799719 0.82 GRM5 (0.45) SSTR4AKT1FPR1FPR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS P2RX7 666/4885TAS1R3 3195/4885TAS1R1 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback